Which Weight Loss Injection Has Fewer Side Effects?
Understanding Wegovy vs Mounjaro Side Effects for Prescription Weight Loss
When comparing Wegovy vs Mounjaro side effects, the fundamental difference lies in their mechanisms of action. Wegovy (semaglutide) targets GLP-1 receptors exclusively, whilst Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors as a dual agonist. This dual action may influence the frequency and intensity of gastrointestinal side effects experienced during treatment. Clinical trials suggest both medications share similar side effect categories, primarily affecting the digestive system during initial weeks of therapy.
The most commonly reported side effects for both Wegovy and Mounjaro include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. However, individual responses vary significantly based on factors including dose escalation speed, dietary habits, and personal tolerance levels. EverydayMeds prescribers conduct thorough assessments to evaluate your medical history and potential risk factors when recommending either prescription weight loss treatment. Understanding these differences helps patients make informed decisions about their weight management journey.
Wegovy vs Mounjaro Side Effects: Pricing and Treatment Value
Both Wegovy and Mounjaro are available through EverydayMeds with transparent pricing structures. Wegovy treatment begins at £79.99 for the 0.25mg starter dose, progressing to £209.99 for the 2.4mg maintenance dose. Our bundles provide treatment continuity - the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, whilst the Ultimate Stability Trio (three 2.4mg pens) is priced at £649.99. Discount codes FIRST40 for new customers and DOSE25 for returning patients are applied at checkout to reach these final prices.
Mounjaro pricing follows a similar structure, reflecting the precision manufacturing required for both GLP-1 and dual receptor agonists. When evaluating Wegovy vs Mounjaro side effects against treatment costs, consider that dose escalation schedules may affect your experience differently. Some patients find Wegovy's single-receptor approach more tolerable, whilst others prefer Mounjaro's dual mechanism. Your prescriber will discuss both options during clinical assessment, ensuring the chosen medication aligns with your budget and tolerance expectations.
Clinical Evidence: Wegovy vs Mounjaro Side Effects Profile
The STEP trial programme, including research by Wilding et al., NEJM, 2021, demonstrated that Wegovy patients experienced predominantly gastrointestinal side effects, with nausea affecting approximately 44% of participants at the 2.4mg dose. Most side effects were mild to moderate and decreased over time as patients adapted to treatment. The systematic dose escalation protocol helps minimise side effect severity whilst maintaining efficacy.
Mounjaro's SURMOUNT trials revealed similar gastrointestinal side effect patterns, though some data suggests the dual receptor mechanism may influence the timing and duration of these effects. Both medications require careful monitoring during initial months, particularly when advancing through dose escalation phases. EverydayMeds provides ongoing support throughout your treatment journey, ensuring any concerns about Wegovy vs Mounjaro side effects are addressed promptly by qualified healthcare professionals.
How Wegovy Works: Understanding Side Effects Through Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate blood glucose and gastric emptying. This mechanism explains why side effects predominantly affect the digestive system - the medication naturally slows gastric emptying, promoting satiety but occasionally causing nausea or delayed digestion. The brain's appetite control centres also respond to GLP-1 activation, reducing food cravings and supporting portion control. Understanding this mechanism helps patients recognise that initial side effects often reflect the medication working as intended. Most patients find that gastrointestinal symptoms improve significantly after 4-8 weeks as their body adapts to the treatment protocol.
Ordering Process for Wegovy vs Mounjaro Side Effects Assessment
EverydayMeds streamlines the process of evaluating Wegovy vs Mounjaro side effects through our comprehensive 3-minute online clinical assessment. This evaluation covers your medical history, current medications, previous experiences with similar treatments, and specific concerns about potential side effects. Our prescribers review applications within 3 working days (24 hours for express service) and recommend the most suitable option based on your individual profile. Once approved, we dispatch medications via next-day cold-chain delivery, maintaining optimal storage conditions throughout transport. This careful process ensures you receive the right prescription weight loss treatment whilst minimising the risk of adverse reactions.
Storage and Practical Considerations: Wegovy vs Mounjaro Side Effects Management
Both medications require refrigeration at 2-8°C before first use, though Wegovy offers superior travel flexibility with 6 weeks room temperature storage versus Mounjaro's 21 days. The FlexTouch pen design used for Wegovy provides precise dosing, reducing the risk of administration errors that might increase side effect likelihood. Proper storage maintains medication potency and reduces the risk of injection site reactions. Dose escalation schedules are mandatory for both treatments - starting at lower doses and gradually increasing helps minimise side effects whilst allowing your body to adapt. Never skip dose escalation steps, as this significantly increases the risk of gastrointestinal side effects and treatment intolerance.
Personalised Side Effect Risk Assessment for Prescription Weight Loss
Individual factors significantly influence how patients experience Wegovy vs Mounjaro side effects, making personalised assessment crucial for treatment success. Patients with sensitive stomachs, previous bariatric surgery, or gastroparesis may require modified dose escalation schedules or alternative medication choices. EverydayMeds prescribers evaluate these risk factors during clinical assessment, tailoring recommendations to minimise adverse reactions whilst maximising treatment efficacy.
Age, concurrent medications, and underlying health conditions also affect side effect profiles when comparing Wegovy vs Mounjaro options. Our clinical team considers these variables alongside your weight loss goals and lifestyle factors. This comprehensive approach ensures that patients receive appropriate prescription weight loss treatment with realistic expectations about potential side effects and management strategies.
Getting Started: Your Next Steps for Safe Weight Loss Treatment
Both Wegovy and Mounjaro are available through EverydayMeds with expert clinical guidance to minimise side effect risks and optimise treatment outcomes. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine prescription-only medicines with appropriate safety monitoring throughout your journey. Complete your 3-minute assessment today using discount code FIRST40 for new customers or DOSE25 for returning patients. Remember that both medications must be used alongside a reduced-calorie diet and increased physical activity for optimal results. Start your prescription weight loss consultation at https://everydaymeds.co.uk/collections/wegovy and take the first step towards achieving your weight management goals with professional medical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
